https://ctc.mph.com.tr/tr/immunoterapi-ile-akciger-kanseri-hastalarinin-omru-uzuyor/2024-11-25T10:50:53+03:00https://ctc.mph.com.tr/tr/lutesyum-ile-umutlandiran-tedavi/2024-08-02T14:25:26+03:00https://ctc.mph.com.tr/tr/harvardli-doktorlardan-medical-pointe-ziyaret/2024-08-02T14:26:17+03:00https://ctc.mph.com.tr/tr/medical-pointte-klinik-arastirmalar-merkezi-hizmete-acildi/2024-08-02T13:03:55+03:00https://ctc.mph.com.tr/tr/ieu-klinik-arastirmalar-etik-kurulu-yeni-yonetmelik-dogrultusunda-calismalarina-basladi/2024-08-02T17:50:13+03:00https://ctc.mph.com.tr/tr/klinik-arastirma-merkezimizin-web-sitesi-yayinda/2024-10-26T14:25:32+03:00https://ctc.mph.com.tr/tr/2024-helsinki-deklarasyonu-etik-arastirmada-yeni-bir-donem/2025-01-22T16:46:49+03:00https://ctc.mph.com.tr/tr/tibbi-cihaz-klinik-arastirmalari-icin-yeni-elektronik-basvuru-sistemi/2025-01-22T16:48:26+03:00https://ctc.mph.com.tr/tr/yeni-nesil-evrensel-asi-platformu-salgin-hastaliklara-karsi-daha-guclu-hazirlik/2025-05-06T11:13:43+03:00https://ctc.mph.com.tr/tr/disera-calismasi/2025-06-17T11:05:41+03:00https://ctc.mph.com.tr/tr/prof-dr-isik-tuglular-faz-1-klinik-arastirmalar-merkezimizi-onurlandirdi/2025-08-07T15:24:40+03:00https://ctc.mph.com.tr/tr/biyobenzer-gelistirmede-yeni-donem-fda-reformu-ve-klinik-arastirma-merkezleri-icin-cikarimlar/2025-11-27T09:52:12+03:00https://ctc.mph.com.tr/tr/bolum-2-ab-tibbi-cihaz-yonetmeligi-mdr-ve-ivdr-yeni-donem/2025-11-29T12:10:52+03:00https://ctc.mph.com.tr/tr/bolum-1-tibbi-cihaz-nedir-tanim-ve-kapsam/2025-11-29T12:15:12+03:00https://ctc.mph.com.tr/tr/bolum-3-tibbi-cihaz-siniflandirmasi-risk-temelli-yaklasim/2025-12-01T10:59:15+03:00https://ctc.mph.com.tr/tr/bolum-4-ce-isaretine-giden-yol-ve-teknik-dokumantasyon/2025-12-01T14:42:48+03:00https://ctc.mph.com.tr/tr/bolum-5-klinik-degerlendirme-raporu-cer-kanitin-temeli/2025-12-05T16:01:29+03:00https://ctc.mph.com.tr/tr/bolum-6-klinik-arastirma-zorunluluk-ve-surecler/2025-12-05T16:25:18+03:00https://ctc.mph.com.tr/tr/bolum-7-piyasaya-arz-sonrasi-klinik-takip-pmcf-ve-surekli-uyum/2025-12-14T19:34:51+03:00https://ctc.mph.com.tr/tr/bolum-8-klinik-arastirma-yonetimi-ve-mdr-sureclerinde-rekabet-avantaji/2025-12-18T11:44:08+03:00https://ctc.mph.com.tr/tr/nobel-ilactan-medical-point-faz-1-merkezine-onemli-ziyaret/2025-12-19T10:51:26+03:00https://ctc.mph.com.tr/tr/bolum-9-uluslararasi-regulasyonlar-eu-mdr-ve-us-fda-karsilastirmasi/2026-01-02T12:34:22+03:00https://ctc.mph.com.tr/tr/klinik-arastirmalarda-yapay-zeka-devrimi-guvenilirligin-10-temel-prensibi/2026-01-19T11:23:33+03:00https://ctc.mph.com.tr/tr/klinik-arastirmalarda-teknolojik-ve-regulatif-donusum-sentetik-kontrol-kollari-yapay-zeka-entegrasyonu-ve-2026-vizyonu/2026-03-07T12:34:18+03:00https://ctc.mph.com.tr/tr/kuresel-klinik-arastirma-ekosisteminde-yeni-ufuklar-faz-1-arastirmalarinda-teknolojik-donusum-veri-analitigi-ve-2026-vizyonu/2026-04-21T17:24:49+03:00